EXAMEN DE SEMIOLOGIA ENDOCRINA

1.- MENCIONES LAS PRINCIPALES CARACTERISTICAS DE LA

ALDOSTERONA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
2.- ESTIMULOS QUE PROMUEVEN LA SECRECION DE ALDOSTERONA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
3.- EFECTOS BIOLOGICOS FINALES EN SITUACIONES DE
HIPERALDOSTERONEMIA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
4.- MENCIONE LOS GLUCOCORTICOIDES MS IMPORTANTE Y SUS
CARACTERISTICAS:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
5.- COMO ACTUA LOS GLUCOCORTICOIDES A NIVEL DE LAS PROTEINAS:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
6.- EFECTOS BIOLOGICOS EN SITUACIONES DE HIPERCORTISOLEMIA,
DEPENDIENTES DE LA ACCION GLUCOCORTICOIDE:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________

7.- TODA VEZ QUE SE IDENTIFIQUE EN UN PACIENTE, DIFICULTAD PARA

MANTENER LA GLICEMIA NORMAL EN LOS PERIODOS INTERDIGESTIVOS,
ASOCIADA A:
__________________; ___________________; _________________________
SE PLANTEARA EL DIAGNOSTICO CLINICO DE
______________________________________________
Y EL PLAN DIAGNOSTICO SERIA:
________________________________________________________________
8.- DEFINICION DECLARATIVA DE POLIUREA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
9.- EXCLUYENDO LA OSMOLARIDAD PLASMATICA COMO FACTOR QUE
INFLUYE EN LA SECRECION DE ANTIDIURETICA, MENCIONE 5 FACTORES
QUE REDUCEN LA SECRECION DE ANTIDIURETICA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
10.- EN LA REGULACION ANATOMOFUNCIONAL DEL HIPOTALAMO CON
LA HIPOFISIS POSTERIOR SE PUEDE AFIRMAR LO SIGUIENTE:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
11.- SE HA IDENTIFICADO COMO UNA ZONA NEURONAL SECUNDARIA,
IMPORTANTE PARA EL CONTROL DE LA OSMOLARIDAD Y LA
REGULACION DE LA SECRECION DE ADH:
___________________________________________________________________
12.- DEFINICION OPERATIVA DE HIPONATREMIA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________

______________________________________________________________________
______________________________________________________________________
13.- TODA VEZ QUE SE IDENTIFIQUE UN PACIENTE CON HIPONATREMIA
HIPOTONICA, NO ASOCIADO A ___________________ NI
____________________,
SE PLANTEARA LOS POSIBLES DIAGNOSTICOS DE:
______________________________________________
______________________________________________
EL PLAN DIAGNOSTICO SERIA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
14.- MECANISMO DE ACCION DE LA HORMONA DEL CRECIMIENTO:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
15.- NUCLEO HIPOTALAMICO QUE INDUCE LA SECRECION DE GHTH:
_________________________________________
16.- FACTORES ENDOGENOS QUE INFLUYEN EN EL CRECIMIENTO
LONGITUDINAL:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
17.- MENCIONE 4 SIGNOS TIPICOS RELACIONES A LA GH EN LA
ACROMEGALIA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
18.- EXAMENES DE AYUDA AL DIAGNOSTICO DEL SINDROME DE TALLA
ALTA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________

______________________________________________________________________
______________________________________________________________________
19.- SINDROME DE TALLA BAJA HIPOFISIARIA, DEFINICION
DECLARATIVA:
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
20.- SINDROME DE TALLA BAJA HIPOFISIARIA PATOLOGICA:
INDICADOR: __________________________________________________________
PUEDE SER: _______________, _____________________
EN EL CASO DE LA SEGUNDA MENCIONE PATOLOGIAS:
__________________; _________________________